Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...
As global markets react to rising U.S. Treasury yields and a tempered outlook for Federal Reserve rate cuts, small-cap stocks have felt the pressure more acutely than their large-cap counterparts. In ...
BARCELONA - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), the global healthcare company known for its plasma-derived medicines, has received U.S. FDA approval for its Fibrin Sealant (FS) for use in ...
Some results have been hidden because they may be inaccessible to you